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1. Introduction 
A special class of plasma membrane K’conductance 
specifically activated by cytoplasmic [Ca*‘] was first 
described in human red blood cells [ 11, and later 
shown to occur in a large variety of vertebrate cells, 
where it plays an important regulatory role [2]. The 
mechanism by which Ca2+ activates K’ conductance 
is, however, unknown. 
of the same cells, a calmodulin-independent enzyme, 
that is inhibited non-specifically only by high drug 
concentrations [5-71. 
2. Materials and methods 
The ubiquitous calcium-binding protein calmodu- 
lin, on the other hand, has been shown to mediate a 
very large number of intracellular effects of calcium 
[3]. A number of phenothiazines, such as chlorprom- 
azine, trifluoperazine and fluophenazine; of diphenyl- 
butyl piperidine neuroleptics, such as pimozide, pen- 
fluridol and fluspirilene [4-61; or the drug N-(6-ami- 
nohexyl)-5-chloro-I-naphtalenesulfonamide (W-7) [7] 
within a certain concentration range, specifically 
inhibit the calcium-calmodulin complex. 
These experiments were done to find out whether 
calmodulin participates in the mechanism by which 
Ca*+ activates plasma membrane K+-conductance. 
They were prompted by the finding that high chlor- 
promazine concentrations (0.15 mM) are able to 
inhibit Ca*+-activated K+-conductance [8]. For this 
we have measured, using a K’-sensitive electrode, net 
K+-efflux from human red blood cells under control 
conditions or when Ca**-influx was raised by using 
the ionophore A-23187, and tested the effect of 6 of 
the above calmodulin-specific inhibitors, on this Ca*+- 
activated K+-conductance. To test whether the marked 
inhibitory effects found with these drugs were specific, 
we have compared them with those reported, that the 
same drugs have on human erythrocyte Ca*+-activated 
ATPase, a well established calmodulin-requiring 
enzyme [9 ,101, or on basal membrane Mg2+-ATPase 
The rate of net K+-efflux from human blood bank 
erythrocytes was measured essentially as in [8]: Red 
cells were washed twice by centrifugation at room 
temperature, for 10 min at 1000 X g, in 0.15 M NaCl. 
Each time, before resuspending the pellet, the upper 
l/4 of it was aspirated, to eliminate non-red cells. A 
third wash was done in the medium (mM): NaCl 135; 
KC1 0.2; MgC12 1; CaClz 1; Hepes-NaOH (pH 7.4) 
buffer 20) [8]. Finally the cells were incubated at an 
hematocrit of 2.5%, at 25’C with stirring, in a final 
volume of 10 ml, in the above medium [8]. Potassium 
in the medium [S] was measured continuously by 
means of a Radiometer F23 12K electrode. Ionophore 
A-23187 was added in 9 ~1 absolute ethanol, to give a 
0.5 @I final cont. At the end of the experiment, the 
red cells were lysed by adding 2 ~1 Triton X-100, so 
that their total [K’] could be estimated. 
Chlorpromazine and W-7 were kind gifts of Profes- 
sors C. MuHoz and H. Hidaka, respectively; pimozide, 
penfluridol and fluspirilene were donated by Janssen 
Pharmaceutics, and fluphenazine by Schering. 
3. Results 
In the absence of A-23187, the rate constant (k,) 
of net K+-loss from the erythrocytes was found, at 
25”C, to be 0.00245 + 0.00032 min-’ (N = 18) 
(fig.l), and did not change over 45 min incubation, 
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Fig.1. Effect of ionophore A-23187, fluphenazine and chlor- 
promazine on K’-loss. Potassium remaining in the erythro- 
cytes (log scale), is plotted against time. In all cases 0.5 PM 
A-23187 was added at 16 min; k, is the rate constant of 
K*-loss prior to A-23187;k, is that seen following addition 
of A-23187. k was calculated as 2.303/t log K, /K,, where K, 
is the [K*] at the beginning of any interval, K, that at the 
end of the interval, and t the duration of the interval. 
or when ethanol up to 1% was added (not shown). 
When 0.5 /J.M A-23187 was present (fig.l), the rate 
constant (k,) of K+-efflux increased 20-fold to 
0.05032 + 0.00118 min-’ (N= 18). This Ca2+-stimu- 
lated K+-loss remained exponential at least until 80% 
of the cell K+ was lost (not shown). Chlorpromazine, 
even at the highest concentration tested (100 PM) did 
not change kl (fig.l), but all the other drugs tested 
increased kl in variable proportion. This was most 
marked with high concentrations of fluphenazine 
(fig.1) or W-7, that markedly increased kl, but only 
moderate with diphenylbutyl piperidine neuroleptics, 
where kl increased at most 2-fold, against lo-fold seen 
with 0.25 @I W-7. Because of these effects on kl, 
drug effects are better expressed by measuring their 
action on the change in rate constant (i.e ., k2- kl) 
induced by A-23187. 
The diphenylbutyl piperidine neuroleptics pimo- 
zide, penfluridol and fluspirilene were all potent inhib- 
itors of Ca2+-activated K’conductance (fig.2). This 
effect had a concentrationdependence that was quite 
similar to their effects on calmodulindependent Ca’+- 
ATPase, but markedly different from non-specific 
effects on calmodulin-independent (basal) ATPase of 
human red blood cells. Chlorpromazine also showed a 
similar concentrationdependency in the inhibition of 
Ca*+-activated K+-conductance relative to Ca*‘-ATPase, 
while fluphenazine deviated from the general pattern 
(fig.3). Methylene blue, that also has a phenothiazine 
nucleus, up to 0.5 mM, and tested at 25°C or 37”C, 
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Fig.2. Inhibition of Ca*+-activated K+-conductance (gK) by 
pimozide, penfluridol and fluspirilene; % inhibition is plotted 
against drug concentration (log scale). Inhibition of gK is 
compared with that of calmodulin-activated Cal’-ATPase 
(CAL), and with basal, calmodulinindependent Mg2+-ATPase 
(non-specific), obtained with the same drugs in [5]. 
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Fig.3. Inhibition of Ca*+-activated K’-conductance r&K) by Fig.4. Inhibition of Ca2+-activatedgK by W-7. CAL and TnC 
fluphenazine and chlorpromazine. Symbols as in fig.2. Inhibi- represent calrnodulin or troponin C-activated Ca-ATPase, 
tion of Ca2’-ATPase (CAL) and of Mg”-ATPase (non-specific) respectively, while non-specific indicates basal ATPase. The 
was calculated from [S]. 3 latter values were calculated from [ 71. 
was entirely inactive on Ca’+-activated K+-conductance 
(6 expt, not shown). The calmodulin-inhibitor W-7 
was also quite active as an inhibitor of Ca2+-activated 
K+-conductance, and its potency was comparable to 
that shown on calmodulin or troponin C-activated 
Ca’+-ATPase, but quite different from those on basal 
Ca2+-ATPase (fig.4). 
Inhibition of Ca2+-activated K+-conductance by 
the calmodulin inhibitors studied, with the exception 
of fluphenazine, showed a high degree of correlation 
(r = 0.988) with the effect of these drugs on human 
red blood cell Ca”-ATPase, a well-established, calmo- 
dulindependent enzyme (fig.5). 
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Fig.5. Correlation of inhibition of Ca’+-activated K+-conduc- 
tance with that of calmodulinactivated Ca2’-ATPase. Corre- 
lation coefficient r is calculated for all drugs except fluphena- 
zinc. Slope of the regression line for the same group of drugs 
was 0.694. For pirnozide, penfluridol and fluspirilener was 
0.987 and the slope 1.02. 
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4. Discussion 
The finding that several of the drugs used here are 
potent inhibitors of Ca’+-activated K+-conductances is 
of interest, because of the small number of substances 
presently known to inhibit that mechanism [8,11- 131. 
Although it is now established that calmodulin is 
not the receptor for the neuroleptic effect of pheno- 
thiazines or diphenylbutyl piperidines [6,14], several 
of these drugs do, nevertheless, inhibit numerous cal- 
modulin-mediated calcium effects, at drug concentra- 
tions that are -1 O-fold lower than those at which non- 
specific drug effects are seen [S-7,15]. The high cor- 
relation found between inhibition of Ca’+-activated 
Kf-conductance and (Ca*’ + Mg”)-ATPase, an estab- 
lished calmodulindependent enzyme, as well as the 
marked differences with the calmoduhn-independent 
Mg”-ATPase, suggest hat calmodulin, or a closely 
related protein, may mediate Ca” effects on K+-con- 
ductance. However, this should be confirmed by iso- 
lation and purification of the membrane components 
responsible for this mechanism. 
The possible participation of tightly-bound calmo- 
dufin in Ca*+-activated K+-conductance is of interest, 
because this mechanism is known to exist in 2 states: 
one with high and the other with low affinity for cal- 
cium [16]. The latter form could be due to the pres- 
ence of an endogenous inhibitor of calmodulin, which, 
when lost, could switch the system to one with high 
Ca*+ affinity. 
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